ISSN 3080-7611(Print)
ISSN 3080-762X(Online)
版权信息 · Copyright

     加入编委 / 副主编 / 同行评议专家
ISSN 3080-7611(Print)
ISSN 3080-762X(Online)

CODEN:ZLYABX
国际标准连续出版物标识符·全球唯一标识符
分配机构:美国化学文摘社(CAS)
DOI前缀:
https://doi.org/10.66106/zlyabx
国图集团 CIBTC
进口备案刊号:G015Z110

索引 检索 存档(Global Indexing)
本刊入选以下全球权威数据库,致力于研究成果的全球化无障碍传播。

CNKI(中国知网,申请中)
CNKI Open(中国知网·开放平台,申请中)
Wanfang Data(万方数据,中国,更新中)
CQVIP(维普期刊网,中国)
CQVIP(中文期刊服务平台,中国)
RCCSE(中国学术期刊目录,武汉大学)
CJWK(长江文库,中国)
BOOKAN(博看,中国)
591adb(中邮阅读·万章期刊,中国)
Baidu Scholar(百度学术,中国)
Baidu Baike(百度百科,中国)
ICI(哥白尼期刊数据库,波兰)
EuroPub(欧洲学术出版数据库,英国)
MDPI scilit(科学与学术数据库,瑞士)
Crossref(交叉引用,美国)
Semantic Scholar(语义学术,美国)
OpenAlex(全球开源学术平台,加拿大)
ACADEMIA.EDU(学术界,美国)
OUCI(开放乌克兰科学,乌克兰)
WorldCat(世界编目数据库,美国)
Scite(智能引文分析数据库,美国)
The Lens(透镜学术,澳大利亚)
OpenAIRE(开放学术发现门户,欧洲)
Google Scholar(谷歌学术,美国)
DOI(数字对象唯一标识符,英国)
Portico(数字存储库,美国)
J-Gate(开放获取期刊门户,印度)
ResearchGate(研究之门,德国)
Research Commons(科睿唯安,美国)
Socolar(开放获取资源检索,中国,更新中)
Sci Online(科学在线,中国澳门)
OALib(开放存取资源图书馆,美国)
EZB(电子期刊图书馆,德国,申请中)
Road(开放科学学术资源,法国)
ISI(国际科学索引平台,阿联酋迪拜)
ASCI(亚洲科学引文索引,美国)
ESJI(欧亚科学期刊索引,哈萨克斯坦)
ResearchBib(研究者索引,日本)
SPI-Hub™(范德比尔特大学,美国)
SJIF(科学期刊影响因子,印度)
RJIF(研究期刊影响因子)
COSMOS(期刊评价指标,印度)
LivRe!(开放期刊门户,巴西)
KIND CONGRESS(阿塞拜疆)
Journament(质量评估与索引)
IP Indexing(ip索引)
Magzter(跨平台数字期刊,美国)
SlideShare(知识共享平台,美国)
SCRIBD(在线图书馆,美国)
Yahoo! Search(雅虎,美国)
Microsoft Bing(微软学术,美国)
LibKey(学术文献快捷获取工具)
R Discovery(研究者发现平台,印度)
Enterscholar(恩特学术)

规划申请

SinoMed 中国生物医学文献服务系统
EBSCO 学术文献数据库(美国)

CABI 国际农业与生物科学中心(英国)
RePEc 经济研究文献数据库(美国)
OAJ 全球OA期刊索引(中国)
DOAJ 开放获取期刊目录(瑞典)
PubMed 医学文摘数据库(美国)
PubMed Central 医学全文数据(美国)
Scopus 爱思唯尔·斯高帕斯(荷兰)
EMBASE 爱思唯尔·医学文摘(荷兰)
ProQuest 科睿唯安(美国)
Research4Life 世界卫生组织数据库

Editing and Publishing
Quest Press Limited
Address
Unit D, 7th Floor, No. 19, Rua de Pa̍k-chiông Vai, Macau
Telephone
+853 6881 9699
Email
QuestPress@hotmail.com
Web site
https://zwlc.scionline2025.com
  往期阅览 · All Issues-> 2025年 · 2025  
中外临床医学2025年第1卷第3期第19-22页,pISSN 3080-7611、eISSN 3080-762X 发布者:Quest Press 发布日期:2026/1/11
Open Access 浏览489

 

(1,3) -β-D 葡聚糖与半乳甘露聚糖联合检测对侵袭性曲霉菌感染的研究分析


高文英,董海威,李永琦,耿丹,吴杉杉

太原金域临床检验所有限公司,山西太原,030000

摘要:目的 研究侵袭性曲霉菌感染(invasive aspergillosis,IA) 情况分析,为侵袭性曲霉菌的临床分析提供参考。方法 以2021 年10月至2022年9月送检太原金域临床检验所有限公司为侵袭性真菌感染(invasive fungal disease,IFD) 患者的标本557 例为研究对象,分析年龄、性别、科室、标本类型对IA 阳性检出结果的影响。结果 557例IFD患者中,检测出为IA阳性的患者为117例(19.75%)。IA阳性主要集中在0~9 岁、50~59 岁、≥ 60 岁年龄段人群,其阳性率分别为40.17%、27.35% 和14.53%。感染科室也主要是呼吸与危重症科39 例、重症科18 例 和儿科17 例,其阳性占比分别为33.33%、15.38% 和14.53%。IA 阳性患者主要患病的季节主要集中在夏秋季节,尤其是秋季(7 月~9 月);不同的标本类型对IA阳性的检出无统计学意义(P> 0.05)。结论 G试验和GM试验对IA有一定诊断价值,而联合检测大大提高了敏感性,对 IA 的诊断更有价值,利于临床医生早期诊断 IA。

关健词::(1,3) -β-D 葡聚糖;半乳甘露聚糖;侵袭性曲霉菌感染
Analysis of Combined (1,3)-β-D-Glucan and Galactomannan Testing for Invasive Aspergillosis

Wenying Gao,Haiwei Dong,Yongqi Li,Dan Geng,Shanshan Wu

Taiyuan KingMed Clinical Laboratory Co.,Ltd.,Taiyuan Shanxi 030000,China

Abstract:Objective To study the status of invasive aspergillosis (IA) and provide a reference for its clinical analysis.Methods A total of 557 specimens from patients with invasive fungal disease (IFD), sent to Taiyuan KingMed Clinical Laboratory Co.,Ltd. between October 2021 and September 2022, were included as the study subjects. The effects of age, gender, department, and specimen type on positive IA detection results were analyzed.Results Among the 557 IFD patients, 117 (19.75%) tested positive for IA. IA positivity was primarily concentrated in the age groups of 0-9 years, 50-59 years, and ≥60 years, with positive rates of 40.17%, 27.35%, and 14.53%, respectively. The main departments with IA-positive cases were Respiratory and Critical Care Medicine (39 cases), Intensive Care Unit (18 cases), and Pediatrics (17 cases), accounting for 33.33%, 15.38%, and 14.53% of positive cases, respectively. IA-positive cases were predominantly identified during the summer and autumn seasons, especially in autumn (July to September). Different specimen types showed no statistically significant difference in the detection of IA positivity (P > 0.05).Conclusion The G-test and GM-test have certain diagnostic value for IA. However, combined testing significantly improves sensitivity, offers greater value for the diagnosis of IA, and is beneficial for clinicians in the early diagnosis of IA.


Keywords : (1,3)-β-D-glucan; Galactomannan; Invasive aspergillosis


参考文献
[1] Martin GS,Mannino DM,Eaton S,et al.The epidemiology of sepsis in the United States from 1979 through 2000[J].N Engl J Med,2003,348: 1546- 1554.
[2] Marr KA,Seidel K,Slavin MA,et al.Prolonged fluconazole prophylaxis is associated with persistent protection against candidiasis-related death in allogeneic marrow transplant recipients: long-term follow-up of a randomized,placebo-controlled trial[J].Blood, 2000,96,2055-2061.
[3] Cordonnier C,Ribaud P,Herbrecht R,et al. Prognostic factors for death due to invasive aspergillosis after hematopoietic stem cell transplantation: a 1-year retrospective study of consecutive patients at French transplantation centres[J].Clin Infect Dis,2006,42: 955-963.
[4] Becker M,de Marie S,Willemse D,et al.Quantitative galactomannan detection is superior to PCR in diagnosing and monitoring invasive pulmonary aspergillosis in an experimental rat model[J].J Clin Microbiol, 2000,38: 1434-1438.
[5] Kontoyiannis DP,Bodey GP.Invasive aspergillosis in 2002: an update[J].Eur J Clin Microbiol Infect Dis, 2002,21: 161-172.
[6] Kedziderska A,Kochan P,Pietrzyk A,et al. Current status of fungal cell wall components in the immunodiagnostics of invasive fungal infections in humans: galactomannan, mannan and 1-3-beta-D glucan antigens [J].Eur J Clin Microbiol Infect Dis,2007.26(11): 755-766.
[7] 张淑瑛,卢小东,王玉月.(1,3) -β-D- 葡聚糖和半乳甘露聚糖抗原联合检测对侵袭性真菌感染的诊断价值[J].中江苏大学学报( 医学版),2014,24(6):495-496.
[8] 潘玲,卢小东,王玉月.(1,3) -β-D- 葡聚糖和半乳甘露聚糖抗原联合检测对侵袭性真菌感染的诊断价值[J]. 中江苏大学学报( 医学版),2014,24(6):495-496.
[9] 慧燕霞,卢岳虹,宋策,等.支气管镜下肺泡灌洗液半乳甘露聚糖试验联合(1,3) -β-D- 葡聚糖检测对肺曲霉菌病的诊断价值[J]. 中国内镜杂志,2019,25(8): 5-9.
[10] 杨婧,刘善收,李俊杰,等.(1,3) -β-D- 葡聚糖与半乳甘露聚糖检测对急诊非粒细胞缺乏症患者侵袭性真菌感染的诊断价值研究[J].临床急诊杂志,2017,18(10):772-774.
论文收录证明 / 文献检索报告
Document Retrieval Certificate / Proof of Publication Indexing
作者贡献声明 / 贡献确认书
Author Contribution Statement / Certificate of Authorship Contribution
同行评审报告 / 评审意见
Peer Review Report / Peer Review Comments
利益冲突
Conflict of Interest
作者声明不存在任何利益冲突。
The author declares no conflict of interest.
版权声明
Copyright Statement
本文采用知识共享“署名 4.0 国际”许可 (CC BY 4.0) 进行许可。许可协议详情请访问: https://creativecommons.org/licenses/by/4.0/
This article is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). For details of the license, please visit:https://creativecommons.org/licenses/by/4.0/.

 
Peer Review
同行评审
Editorial Services
编辑服务
Research Ethics Policy
研究伦理政策
Contributorship & Authorship
贡献者与署名
Quest Press / Macau Sino-Foreign Medical Publishing Ltd.
关于 Quest Press / Macau Sino-Foreign Medical Publishing Ltd.
Global Indexing
全球索引
Copyright Licensing
版权许可
Data Sharing Policy
数据共享政策
Appeal/Correction/Retraction
申诉/更正/撤回
Online Submission
线上投稿
To the Librarian
致图书馆员
Open Access Statement
开放获取声明
Misconduct Handling Policy
处理不端行为政策
Content Licensing
内容许可
Guidelines for Reviewers
审稿人指南
Quality Control Mechanism
质量把控机制
Academic Misconduct Screening Policy
学术不端筛查政策
Advertising Policy
广告政策
Article Processing Charge (APC)
文章处理费
Publication Ethics Policy
出版伦理政策
Joining the Editorial Board, Associate Editors, Peer Reviewers, and Editor-in-Chief
加入编委、副主编、同行评审专家及主编
Quest Press
Bridging Research to a Global Stage.
academia
© 2025-2026 Quest Press Ltd.
Address: Unit D, 7th Floor, No. 19, Rua de Pa̍k-chiông Vai, Macau
Tel: +853 6881 9699 / Email: QuestPress@hotmail.com
The QUEST PRESS publishes articles under the following open access license.
Quest Press
is a member of the following organizations.